BMAY, officially the Innovator U.S. Equity Buffer ETF - May, is an exchange-traded fund that belongs to a family of "defined outcome" or "buffer" products. An ETF is a fund that trades on an exchange like a stock and holds a portfolio of assets. Rather than simply owning shares of companies, BMAY uses options to give investors exposure to the S&P 500 with a built-in downside buffer, making it a distinctive tool for risk-conscious equity investors.
BMAY is issued by Innovator Capital Management (known as Innovator ETFs), a firm that specializes in defined outcome and buffered ETFs. The fund was launched on April 30, 2020, and is co-managed with Milliman Financial Risk Management LLC. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The fund's investment objective is to provide returns that generally match the performance of the State Street SPDR S&P 500 ETF Trust (SPY), up to a predetermined upside cap, while buffering against the first 9% of SPY's losses over a specific one-year outcome period that resets each May. This is a "defined outcome" strategy, meaning the fund targets a known range of potential returns over the measurement period rather than simply tracking the market day to day.
BMAY is actively managed and does not track a traditional index. Instead, it invests primarily in FLexible EXchange (FLEX) options that reference SPY, along with cash and short-term collateral. The fund is non-diversified and must be held for the full outcome period for investors to have the best chance of realizing the intended buffer and cap. The targeted buffer and cap do not include the fund's expense ratio.
Because BMAY is built from derivatives rather than direct stock ownership, its portfolio holdings are concentrated in a small number of option positions on SPY, supplemented by cash and money-market instruments. As a result, the fund's effective equity exposure broadly mirrors the sector allocation of the S&P 500 — typically weighted toward technology, financials, communication services, and healthcare — but the holdings list itself consists of options contracts rather than hundreds of individual stocks.
This structure gives BMAY a distinctive financial profile. Its net asset value (NAV), or the per-share value of the fund's underlying assets, is calculated daily and may differ slightly from its market price. The fund carries a net expense ratio of 0.79%, which investors pay annually as a cost of ownership.
BMAY attracts attention from investors who want to remain invested in U.S. large-cap equities but are concerned about downside risk. The fund's defining feature — a buffer against the first 9% of losses in SPY over the outcome period — offers a form of built-in risk management that conventional index funds do not provide. This makes BMAY a potential candidate for portfolio allocation during periods of elevated uncertainty or for investors nearing a financial goal who wish to reduce short-term drawdown exposure.
The trade-off is the upside cap, which limits gains in strongly rising markets. Investors accept this ceiling in exchange for the downside protection. BMAY is one of a monthly series of Innovator buffer ETFs, allowing investors to select a product whose outcome period aligns with their own investment timing.
Several factors are important to understand before considering BMAY. The buffer and cap apply only to the specific one-year outcome period; investors who buy or sell shares mid-period may receive a very different level of protection and upside participation. The issuer publishes effective interim levels daily, but the intended results are generally only realized if the fund is held for the full outcome period.
The fund is non-diversified, meaning it is not subject to the same diversification requirements as many conventional funds, and its performance is concentrated in options on a single underlying ETF. Because the strategy is built on price-return options, investors do not receive the dividend income typically associated with owning the underlying stocks. BMAY also carries market risk: while it buffers the first 9% of losses, declines beyond that threshold are still fully experienced by investors. The expense ratio of 0.79% additionally reduces returns over time.
BMAY stands out as a defined outcome ETF that pairs large-cap U.S. equity exposure with a structured downside buffer, offering investors a way to participate in the S&P 500 while accepting a cap on gains in exchange for protection against the first portion of losses. Its options-based design, annual reset mechanism, and 0.79% expense ratio make it a specialized tool best understood as a risk-managed alternative to conventional index exposure rather than a straightforward substitute for one.
In my own research process, Tickeron’s AI Screener has proven useful for quickly filtering defined outcome ETFs like BMAY against peers based on volatility, trends, and custom criteria. It helps surface ideas that align with specific risk-managed strategies without sifting through endless data manually.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
The Aroon Indicator for BMAY entered a downward trend on November 17, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 97 similar instances where the Aroon Indicator formed such a pattern. In 73 of the 97 cases the stock moved lower. This puts the odds of a downward move at 75%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMAY as a result. In 36 of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 51%.
The Moving Average Convergence Divergence Histogram (MACD) for BMAY turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 18 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 42%.
BMAY moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BMAY crossed bearishly below the 50-day moving average on November 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMAY advanced for three days, in 238 of 365 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
BMAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.